Xuchen Song

机构：Shenyang Pharmaceutical University, Peking University, Peking University People's Hospital · ORCID：0000-0002-5932-6916

发表论文 8 篇 · 总被引 10 次 · h-index 1

代表论文

• Intersection of immune signaling and cell death: The bidirectional regulatory mechanism of STING pathway and Ferroptosis (2025 · Autoimmunity Reviews · 被引 8)
• Prediction and inversion methods for gas atomization metal powder size distribution inspired by fine tuning the large-scale pre-trained language models (2025 · Powder Technology · 被引 1)
• HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation (2026 · Journal of the American Heart Association)
• Population Pharmacokinetic Analyses and Exposure–Efficacy Relationships of Venetoclax in Chinese Pediatric Patients with Hematological Malignancy in a Real‐World Setting (2026 · Dove Medical Press (Taylor and Francis Group))
• Population Pharmacokinetic Analyses and Exposure–Efficacy Relationships of Venetoclax in Chinese Pediatric Patients with Hematological Malignancy in a Real‐World Setting (2026 · Drug Design Development and Therapy)
• Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics (2026 · Antimicrobial Agents and Chemotherapy)